PTIX Rentabilitas dodolan miturut bathi resik Protagenic Therapeutics

Tandha merek Protagenic Therapeutics Inc. (PTIX)

High certification costs and peptide patent protection limit entry into the Protagenic Therapeutics (PTIX) niche. Business development relies on alliances with scientific centers, which attracts the attention of potential buyers. The company is currently developing antidepressants with a scheduled release in 2026. Net margin dynamics demonstrate sales profitability, where the indicator value stands at 0.00.

PTIX: Rentabilitas resik perusahaan protagenic.com 04.07.2022 - 10.01.2026

Rincian analitis perusahaan Protagenic Therapeutics

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:Protagenic - PTIX
Barang unggulan protagenic.com

An investment audit of the issuer requires a precise assessment of profit generation efficiency before purchasing the asset. This metric is calculated as the ratio of net income to total revenue, determining the real profitability of each unit of sales. For Protagenic Therapeutics (PTIX), this indicator depends directly on the optimization of the costly cold chain during peptide delivery. Logistics diversification minimizes costs, preventing capital erosion. The history of net profit margins clearly demonstrates the business model's resilience to operational shocks.

Analisis pesaing

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|Margin resik NERV|Margin dodolan resik ATHA|ADXN (Addex Therapeutics Ltd) - Tingkat bathi resik|Margin resik alzamend.com ALZN|Margin dodolan perusahaan Cyclerion Therapeutics (CYCN)|KTTA: Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik CRGT (cortigent.com)|ATXI: Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics) - Margin resik|CARA (Cara Therapeutics Inc.) - Margin dodolan resik|Margin resik CHRO|Rentabilitas dodolan miturut bathi resik ELYM (Eliem Therapeutics)|Margin resik ITCI (Intra-Cellular Therapies Inc.)|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel